NLM Logo

Certolizumab Pegol MeSH Descriptor Data 2023


MeSH Heading
Certolizumab Pegol
Tree Number(s)
D05.750.741.125
D12.644.541.500.650.250
D12.776.124.486.485.114.224.060.500
D12.776.124.486.485.680.650.250
D12.776.124.790.651.114.224.060.500
D12.776.124.790.651.680.650.250
D12.776.377.715.548.114.224.200.500
D12.776.377.715.548.680.650.250
Unique ID
D000068582
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068582
Scope Note
A polyethylene-glycolated Fab' fragment of TUMOR NECROSIS FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and IL-1 BETA and is used to treat RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
Entry Term(s)
CDP 870
CDP870
Cimzia
Pharm Action
Tumor Necrosis Factor Inhibitors
Immunosuppressive Agents
Antirheumatic Agents
Registry Number
UMD07X179E
Related Numbers
428863-50-7
See Also
Tumor Necrosis Factor-alpha
Public MeSH Note
2016; CERTILIZUMAB PEGOL was indexed under IMMUNOGLOBULIN FAB FRAGMENTS 2003-2015, POLYETHYLENE GLYCOLS 2003-2015, and under ANTIBODIES, MONOCLONAL, HUMANIZED 2003-2015
History Note
2016 (2003)
Date Established
2016/01/01
Date of Entry
2015/07/10
Revision Date
2021/07/01
Certolizumab Pegol Preferred
Cimzia Narrower
CDP870 Narrower
page delivered in 0.205s